These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10720426)

  • 21. Defective osteoblast function in ICAP-1-deficient mice.
    Bouvard D; Aszodi A; Kostka G; Block MR; Albigès-Rizo C; Fässler R
    Development; 2007 Jul; 134(14):2615-25. PubMed ID: 17567669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
    Wiren KM; Toombs AR; Semirale AA; Zhang X
    Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
    Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
    Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
    J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
    Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
    J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered osteoclast development and function in osteopontin deficient mice.
    Franzén A; Hultenby K; Reinholt FP; Onnerfjord P; Heinegård D
    J Orthop Res; 2008 May; 26(5):721-8. PubMed ID: 18050311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone.
    Salie R; Kneissel M; Vukevic M; Zamurovic N; Kramer I; Evans G; Gerwin N; Mueller M; Kinzel B; Susa M
    Bone; 2010 Mar; 46(3):680-94. PubMed ID: 19857617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation.
    Li B; Boast S; de los Santos K; Schieren I; Quiroz M; Teitelbaum SL; Tondravi MM; Goff SP
    Nat Genet; 2000 Mar; 24(3):304-8. PubMed ID: 10700189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice.
    Ballica R; Valentijn K; Khachatryan A; Guerder S; Kapadia S; Gundberg C; Gilligan J; Flavell RA; Vignery A
    J Bone Miner Res; 1999 Jul; 14(7):1067-74. PubMed ID: 10404006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1.
    Masuda H; Tsujimura A; Yoshioka M; Arai Y; Kuboki Y; Mukai T; Nakamura T; Tsuji H; Nakagawa M; Hashimoto-Gotoh T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):528-33. PubMed ID: 9299545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The osteoblast: an insulin target cell controlling glucose homeostasis.
    Clemens TL; Karsenty G
    J Bone Miner Res; 2011 Apr; 26(4):677-80. PubMed ID: 21433069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the osteoblast lineage.
    Aubin JE
    Biochem Cell Biol; 1998; 76(6):899-910. PubMed ID: 10392704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.
    Wiren KM; Zhang XW; Toombs AR; Kasparcova V; Gentile MA; Harada S; Jepsen KJ
    Endocrinology; 2004 Jul; 145(7):3507-22. PubMed ID: 15131013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
    Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.
    Zhao G; Monier-Faugere MC; Langub MC; Geng Z; Nakayama T; Pike JW; Chernausek SD; Rosen CJ; Donahue LR; Malluche HH; Fagin JA; Clemens TL
    Endocrinology; 2000 Jul; 141(7):2674-82. PubMed ID: 10875273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restricted expression of Mov13 mutant alpha 1(I) collagen gene in osteoblasts and its consequences for bone development.
    Kratochwil K; Ghaffari-Tabrizi N; Holzinger I; Harbers K
    Dev Dyn; 1993 Dec; 198(4):273-83. PubMed ID: 8130375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epigenetic influence of growth hormone on skeletal development.
    Vogl C; Atchley WR; Cowley DE; Crenshaw P; Murray JD; Pomp D
    Growth Dev Aging; 1993; 57(3):163-82. PubMed ID: 8244621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex.
    Frenkel B; Capparelli C; Van Auken M; Baran D; Bryan J; Stein JL; Stein GS; Lian JB
    Endocrinology; 1997 May; 138(5):2109-16. PubMed ID: 9112411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.